HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Laterra Selected Research

Neurosurgical Procedures

1/2017Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Laterra Research Topics

Disease

71Neoplasms (Cancer)
05/2022 - 01/2002
30Glioblastoma (Glioblastoma Multiforme)
05/2022 - 04/2002
30Glioma (Gliomas)
11/2021 - 01/2002
19Brain Neoplasms (Brain Tumor)
01/2022 - 12/2003
8Medulloblastoma
09/2010 - 10/2005
5Carcinogenesis
01/2022 - 05/2004
5Neoplasm Metastasis (Metastasis)
05/2016 - 06/2003
4Gliosarcoma
04/2011 - 12/2003
3Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 12/2005
3Necrosis
03/2012 - 06/2008
2Hemorrhage
06/2017 - 05/2004
2Breast Neoplasms (Breast Cancer)
01/2011 - 09/2003
2Melanoma (Melanoma, Malignant)
01/2011 - 12/2005
2Colonic Neoplasms (Colon Cancer)
10/2008 - 06/2003
2Infarction (Infarctions)
06/2006 - 04/2004
2Hypoxia (Hypoxemia)
06/2006 - 04/2004
2Central Nervous System Neoplasms
02/2006 - 10/2005
1Fever (Fevers)
05/2020
1Cytopenia
05/2020
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
05/2020
1Vascular Malformations
06/2017

Drug/Important Bio-Agent (IBA)

21Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2013 - 01/2002
18Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2003
10Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2014 - 06/2003
9AmidesIBA
01/2022 - 12/2003
9Protons (Proton)IBA
01/2022 - 12/2003
9Monoclonal AntibodiesIBA
02/2016 - 02/2006
8Glucose (Dextrose)FDA LinkGeneric
05/2022 - 12/2005
7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2002
7Transcription Factors (Transcription Factor)IBA
01/2020 - 02/2008
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2010 - 01/2002
6APTIBA
01/2022 - 12/2003
6Phosphotransferases (Kinase)IBA
04/2016 - 12/2004
5Small Interfering RNA (siRNA)IBA
01/2022 - 04/2010
5Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2009
5EnzymesIBA
05/2021 - 01/2002
5Messenger RNA (mRNA)IBA
04/2010 - 04/2004
5Catalytic RNA (Ribozymes)IBA
06/2005 - 01/2002
4MicroRNAs (MicroRNA)IBA
06/2021 - 07/2015
4GadoliniumIBA
11/2019 - 10/2008
4LigandsIBA
07/2009 - 02/2004
3Biological ProductsIBA
11/2021 - 06/2003
3TenascinIBA
01/2019 - 04/2016
3Peptides (Polypeptides)IBA
08/2012 - 12/2003
3CamptothecinIBA
10/2009 - 06/2005
3Death Domain ReceptorsIBA
10/2009 - 08/2007
2Uridine Diphosphate (UDP)IBA
05/2022 - 01/2018
2CytokinesIBA
01/2022 - 10/2021
2Temozolomide (Temodar)FDA LinkGeneric
11/2021 - 03/2009
2Pharmaceutical PreparationsIBA
05/2021 - 10/2007
2Fatty Acids (Saturated Fatty Acids)IBA
05/2021 - 12/2009
2Extracellular Matrix ProteinsIBA
01/2019 - 01/2018
2Contrast MediaIBA
01/2019 - 12/2015
2Histones (Histone)IBA
10/2018 - 07/2009
2Histone Deacetylase InhibitorsIBA
10/2018 - 06/2012
2IntegrinsIBA
03/2016 - 11/2014
2Ligases (Synthetase)IBA
06/2014 - 12/2009
2Acyl Coenzyme A (Acyl CoA)IBA
06/2014 - 12/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2009 - 06/2005
2fas Receptor (CD95 Antigen)IBA
10/2009 - 06/2005
2HhAntag691IBA
09/2009 - 01/2009
2Adenosine Triphosphate (ATP)IBA
07/2009 - 12/2005
2Mitogen-Activated Protein KinasesIBA
07/2009 - 10/2005
2ErbB Receptors (EGF Receptor)IBA
07/2009 - 01/2008
2Epidermal Growth Factor (EGF)IBA
07/2009 - 01/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2008 - 08/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2005 - 05/2004
2tyrosine receptor (receptor, tyrosine)IBA
06/2005 - 12/2004
1Interleukin-33IBA
01/2022
1ChemokinesIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Doxycycline (Periostat)FDA LinkGeneric
01/2022
1A-Form DNA (A-DNA)IBA
11/2021
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2021
1long-chain-fatty-acid-CoA ligaseIBA
05/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
05/2021
1SphingolipidsIBA
05/2021
1osimertinibIBA
01/2021
1Immune Checkpoint InhibitorsIBA
05/2020
1PyrrolesIBA
05/2020
1AntagomirsIBA
01/2020
1TOR Serine-Threonine KinasesIBA
01/2019
13-O-Methylglucose (3 O Methylglucose)IBA
01/2019
1Sirolimus (Rapamycin)FDA Link
01/2019
1EstersIBA
11/2018
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
10/2018
1PanobinostatIBA
10/2018
1Histone Deacetylases (Histone Deacetylase)IBA
10/2018
1BrevicanIBA
01/2018
1Investigational DrugsIBA
08/2016
1TetraspaninsIBA
03/2016

Therapy/Procedure

31Therapeutics
01/2022 - 04/2004
4Drug Therapy (Chemotherapy)
10/2018 - 06/2005
2Immunomodulation
10/2021 - 01/2019
2Intravenous Injections
01/2019 - 01/2002
2Craniotomy
06/2017 - 01/2010
2Radiotherapy
06/2014 - 03/2009
1Aftercare (After-Treatment)
01/2019
1Neurosurgical Procedures
01/2017
1Immunotherapy
08/2016